Responding to the COVID-19 pandemic, advertising regulators—including the National Advertising Division (NAD) and Federal Trade Commission (FTC)—are cracking down on fraudsters taking advantage of public fears and health concerns brought on by the COVID-19 pandemic. For innovative companies bringing new products to market in response to public demand, however, the strict enforcement environment creates substantially elevated risks, particularly for those making health-related claims about their products or services.

In this episode of Perfect Balance: An Advertising Law Podcast, co-hosts Po Yi and Alexa M. Singh, drawing on the encyclopedic advertising regulatory knowledge of Manatt advertising, marketing and media partner Jeffrey S. Edelstein, take listeners on a tour of key enforcement actions and priorities that marketers should be aware of as regulators crack down on misleading COVID-19-related advertising.

To access other episodes of this podcast, please click here.